This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Sundeep Jaglan: Innovator in Pharmacological Compounds
Introduction
Sundeep Jaglan is a notable inventor based in Jammu, India. He has made significant contributions to the field of pharmacology through his innovative research and development of new compounds. His work focuses on the isolation and application of peptaibols, which are important in medical science.
Latest Patents
Sundeep Jaglan holds a patent for "Brachiatin D and process for production thereof." This invention relates to a peptaibol with the sequence AcAib-Asn-Aib-Leu-Aib-Pro-Aib-Asn-Leu-Pro-Ileuol, which is isolated from an endophytic fungus with accession number MTCC 5721. The peptaibol, named Brachiatin D, is recognized for its potential use as a pharmacologically active compound, particularly as a strong immunosuppressant and anticancer agent.
Career Highlights
Sundeep is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in pharmacological applications. His work has garnered attention for its innovative approach to drug development and its potential impact on healthcare.
Collaborations
Sundeep collaborates with talented individuals in his field, including Deepika Singh and Varun Pratap Singh. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Sundeep Jaglan's contributions to the field of pharmacology through his patent and research highlight his role as an innovator. His work on Brachiatin D showcases the potential of peptaibols in medical applications, paving the way for future advancements in immunosuppressive and anticancer therapies.